Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

<p>Abstract</p> <p>Background</p> <p>Clusterin is a cytoprotective chaperone protein involved in numerous physiological processes, carcinogenesis, tumor growth and tissue remodelling. The purpose of this study was to investigate whether clusterin (CLU), an antiapoptotic...

Full description

Bibliographic Details
Main Authors: Hassan Mohamed K, Watari Hidemichi, Han Yimin, Mitamura Takashi, Hosaka Masayoshi, Wang Lei, Tanaka Shinya, Sakuragi Noriaki
Format: Article
Language:English
Published: BMC 2011-12-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://www.jeccr.com/content/30/1/113

Similar Items